Step by step: BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
BLEST Renews Air Quality Compliance Work at Five Air Force Bases Across New Mexico and Arizona
WESTMINSTER, CA / ACCESS Newswire / July 1, 2026 / BioLargo, Inc. (OTCQX:BLGO),
a cleantech and life sciences innovator and engineering services solution provider, today announced that its engineering subsidiary, BioLargo Engineering, Science & Technologies (BLEST), has received contract renewals totaling more than $1.4 million over 12 months to continue providing air quality and environmental support services at five U.S. Air Force bases.
BLEST serves as a subcontractor to the primary environmental contractors and performs regulatory compliance, permitting, testing, air data management, compliance reporting, and inventory management. The renewals continue ongoing, multi-year work into their next option year.
"These recurring Air Force contracts give BioLargo a base of repeatable engineering revenue, alongside larger engineering projects such as the pilot-scale mineral processing facility announced in April, as well as the company's ongoing product sales," said Dennis P. Calvert, President and CEO of BioLargo, Inc.
"Our teams have supported air quality and environmental compliance at these specific Air Force bases for years. Renewing this work means continuity for the installations and for the specialists who do it, and that continuity is what our prime-contractor partners rely on," said Randall Moore, President of BioLargo Engineering, Science & Technologies (BLEST).
Additional information about BioLargo is available in the company's filings with the U.S. Securities and Exchange Commission and at www.biolargo.com.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease.
Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
See our website at www.BioLargo.com.
CONTACT:
Investor Relations
Matt Kreps
Darrow Associates, Inc.
214-597-8200
mkreps@darrowir.com
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
info@BioLargo.com